PL EN


Preferences help
enabled [disable] Abstract
Number of results
2012 | 84(5) | 238-241
Article title

The -2518 A/G MCP-1 polymorphism as a risk factor of inflammatory bowel disease

Content
Title variants
Languages of publication
Abstracts
EN
Inflammatory bowel diseases (IBD) are disorders originated from immune disturbances. The aim of the study was to evaluate the association between the -2518 A/G MCP-1 polymorphism and the risk of IBD development. Material and methods. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Study group consisted of 197 subjects with IBD (120 with ulcerative colitis and 77 with Crohn’s disease) as well as 210 healthy controls. Results. The presence of the -2518 G/G MCP-1 genotype in the investigated groups seems to be connected with higher risk of inflammatory bowel disease as well as Crohn’s disease only (OR 2.26; 95% CI 1.44-3.54 and OR 2.08; 95% CI 1.21-3.46, respectively). Conclusions. Our data showed that the -2518 A/G MCP-1 polymorphism might be associated with the IBD occurrence and might be used as predictive factor of these diseases in a Polish population.
Year
Volume
Pages
238-241
Physical description
Contributors
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ceon.element-5502d574-abc0-3307-8839-b2fe49c59d41
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.